Half Yearly Results Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Mar'26
Mar'25
Net Sales
197.94
216.55
Other Operating Income
0.00
0.00
Total Operating income
197.94
216.55
Raw Material Cost
48.72
49.62
Purchase of Finished goods
26.00
24.83
(Increase) / Decrease In Stocks
-1.38
38.22
Employee Cost
24.06
15.99
Power Cost
0.00
0.00
Manufacturing Expenses
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
Other Expenses
38.46
43.07
Total Expenditure (Excl Depreciation)
135.86
171.73
Operating Profit (PBDIT) excl Other Income
62.08
44.82
Other Income
3.03
8.52
Operating Profit (PBDIT)
65.11
53.34
Interest
11.11
8.30
Exceptional Items
-0.99
-19.62
Gross Profit (PBDT)
53.01
25.42
Depreciation
6.70
3.21
Profit Before Tax
46.30
22.20
Tax
11.90
15.70
Provisions and contingencies
0.00
0.00
Profit After Tax
34.41
6.50
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
34.41
6.50
Share in Profit of Associates
0.00
2.34
Minority Interest
0.00
0.00
Other related items
0.00
0.00
Consolidated Net Profit
34.41
8.84
Equity Capital
16.28
1.58
Face Value
10.0
10.0
Reserves
0.00
0.00
Earnings per share (EPS)
21.14
55.95
Diluted Earnings per share
21.48
5.61
Operating Profit Margin (Excl OI)
31.36%
20.7%
Gross Profit Margin
26.78%
11.74%
PAT Margin
17.38%
3.0%
Public Share Holdings (%)
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
Half Yearly Analysis Highlights
Net Sales
Growth in half year ended Mar 2026 is -8.46%
Standalone Net Profit
Growth in half year ended Mar 2026 is -6.17%
Operating Profit (PBDIT) excl Other Income
Growth in half year ended Mar 2026 is 39.27%
Interest
Growth in half year ended Mar 2026 is 29.16%
Operating Profit Margin (Excl OI)
Growth in half year ended Mar 2026 has improved from Mar 2025
Compare Half Yearly Results Of Q-Line Biotech With
Figures in Cr
Consolidate Half Yearly Results
Change(INR)
Change(%)
Net Sales
197.94
151.32
46.62
30.81%
Other Operating Income
0.00
0.00
0.00
Total Operating income
197.94
151.32
46.62
30.81%
Raw Material Cost
48.72
17.65
31.07
176.03%
Purchase of Finished goods
26.00
0.00
26.00
(Increase) / Decrease In Stocks
-1.38
0.00
-1.38
Employee Cost
24.06
26.17
-2.11
-8.06%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
38.46
59.63
-21.17
-35.50%
Total Expenditure (Excl Depreciation)
135.86
103.45
32.41
31.33%
Operating Profit (PBDIT) excl Other Income
62.08
47.87
14.21
29.68%
Other Income
3.03
1.76
1.27
72.16%
Operating Profit (PBDIT)
65.11
49.63
15.48
31.19%
Interest
11.11
5.48
5.63
102.74%
Exceptional Items
-0.99
0.00
-0.99
Gross Profit (PBDT)
53.01
44.15
8.86
20.07%
Depreciation
6.70
19.63
-12.93
-65.87%
Profit Before Tax
46.30
24.52
21.78
88.83%
Tax
11.90
6.51
5.39
82.80%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
34.41
18.00
16.41
91.17%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
34.41
18.00
16.41
91.17%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.38
-0.38
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
34.41
18.38
16.03
87.21%
Equity Capital
16.28
10.42
5.86
56.24%
Face Value
10.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
21.14
3.53
17.61
498.87%
Diluted Earnings per share
21.48
3.53
17.95
508.50%
Operating Profit Margin (Excl OI)
31.36%
31.63%
0.00
-0.27%
Gross Profit Margin
26.78%
29.18%
0.00
-2.40%
PAT Margin
17.38%
11.90%
0.00
5.48%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 197.56 Cr
in Mar 2026Figures in Cr
Half Yearly - Standalone Net Profit
Standalone Net Profit 35.42 Cr
in Mar 2026Figures in Cr
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 62.99 Cr
in Mar 2026Figures in Cr
Half Yearly - Interest
Interest 10.72 Cr
in Mar 2026Figures in Cr
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 31.88%
in Mar 2026Figures in %
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
